Nurse Practitioner, Family · Webb City, MO
NPI
1427446202
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
112 N Webb St
Webb City, MO, 64870
Phone (417) 673-0366
Groups this clinician bills Medicare through
Medicare paid, 2024
$536
19 services
Medicare patients, 2024
14
Average age 67
Drug cost, 2024
$976K
8,245 prescriptions
Company payments, 2025
$844
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ashley M Lilienkamp prescribed most often to Medicare patients was Atorvastatin Calcium, with 361 prescriptions and refills. In total Ashley M Lilienkamp wrote 8,245 Medicare prescriptions that cost $976K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 361 | 630 | 66 | $1,876 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 234 | 265 | 54 | $4,688 |
| Lisinopril Generic | 226 | 383 | 40 | $677 |
| Omeprazole Generic | 215 | 315 | 38 | $2,266 |
| Tramadol Hcl Generic | 211 | 212 | 32 | $3,408 |
| Meloxicam Generic | 205 | 304 | 36 | $553 |
| Gabapentin Generic | 203 | 258 | 41 | $3,167 |
| Amlodipine Besylate Generic | 182 | 339 | 44 | $672 |
| Metformin Hcl Generic | 176 | 278 | 34 | $391 |
| Furosemide Generic | 175 | 260 | 34 | $728 |
| Levothyroxine Sodium Generic | 172 | 333 | 33 | $936 |
| Duloxetine Hcl Generic | 141 | 197 | 24 | $2,660 |
| Pantoprazole Sodium Generic | 133 | 254 | 25 | $620 |
| Tamsulosin Hcl Generic | 126 | 199 | 28 | $595 |
| Montelukast Sodium Generic | 124 | 238 | 24 | $993 |
Brand drugs: 1,285 claims; generic drugs: 6,905 claims; opioid claims: 269.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley M Lilienkamp $844 ($844 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $269.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $269 |
| Amgen Inc. AMGN | 6 | $109 |
| Lilly USA, LLC LLY | 5 | $79.82 |
| Dexcom, Inc. DXCM | 3 | $71.71 |
| Pfizer Inc. PFE | 4 | $71.48 |
| Novo Nordisk Inc NVO | 3 | $54.32 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $41.62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $31.47 |
| Exact Sciences Corporation EXAS | 1 | $22.69 |
| Alkermes, Inc. ALKS | 1 | $21.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.